Saturday, June 10, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
AGA Institute
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Professor of Medicine
Chief of Hepatology and Medical Director
Liver Tumor Program
University of Texas Southwestern Medical Center
Dallas, Texas
Medical Oncology
Winship Cancer Institute
Emory Healthcare
Atlanta, Georgia
The opinions expressed are those of Dr Jones and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Jones' participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity is intended for hematology/oncology (hem/onc) specialists, gastroenterologists, nurse practitioners, and nurses.
The goal of this activity is that learners will be better able to identify the prevalence, burden, and consequences of health disparities in the care and outcomes for patients with hepatocellular carcinoma (HCC).
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
AGA Institute
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Professor of Medicine
Chief of Hepatology and Medical Director
Liver Tumor Program
University of Texas Southwestern Medical Center
Dallas, Texas
Medical Oncology
Winship Cancer Institute
Emory Healthcare
Atlanta, Georgia
The opinions expressed are those of Dr Jones and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Jones' participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Developed through a partnership between Medscape and AGA.
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AGA Institute designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; none of these credits is in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 5/3/2022
Valid for credit through: 5/3/2023
processing....
Before you begin, please take this brief survey.
